FDA Clearance Tracker · K171868
A1AT Genotyping Test
Last checked: Nov 21, 2026Latest source record: Nov 11, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Nov 11, 2017
Substantially Equivalent
Time to decision
142 days
Received Jun 22, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K171868
- Device name
- A1AT Genotyping Test
- Applicant location
- Derio, ES
- Received
- Jun 22, 2017
- Decided
- Nov 11, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Serpina1 Variant Detection System (PZH)
- Device class
- Class II
- Regulation
- 21 CFR 866.5130
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PZH (Serpina1 Variant Detection System).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K171868
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Progenika Biopharma S.A., A Grifols Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K221420 · Decided Oct 27, 2022 · 164 days after receipt
Device type: Genetic Variant Detection And Health Risk Assessment System (PTA) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.